Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Iohexol manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

5 products found

iohexol

Solution for infusion 300 mg, 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

This CTD dossier owner and manufacturer is a global producer of pharmaceutical and biotechnology products, specializing in a wide range of therapeutic areas including oncology, infectious diseases (antibiotics, anti-retrovirals, anti-tuberculars), and central nervous system disorders. They offer various dosage forms such as prescription medications, over-the-counter drugs, and medical devices. The company leverages its expertise in API manufacturing and finished product production through partnerships with PIC/S certified facilities. They hold patents and marketing authorizations across multiple regions like the EU and North America. Additionally, they provide consulting, marketing, manufacturing, and technology transfer services within the pharmaceutical industry.

Manufacturer usually replies in 2 days

iohexol

Solution for injection 300 mg/ml, 350 mg/ml - 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Available for Balkans only
Manufacturer #17331
This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

Manufacturer usually replies in 8 days

iohexol

Injection 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Manufacturer usually replies in 2 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Iohexol Manufacturers

Iohexol contains iodine and belongs to a class of drugs known as non-ionic iodinated contrast media or dyes which is an effective non-ionic, water-soluble contrast agent. Iohexol is used in myelography, arthrography, nephron angiography, arteriography, and other radiographic procedures. This medication is advised as a prescription product only. Iohexol is marketed by manufacturers under the Brand name of Omnipaque, Oraltag, Nycodenz. This drug is available in the dosage form of an injection solution, solution, liquid. Iohexol solution is administered via a wide variety of routes like intravenously, intravascularly, intra-articularly, oral, rectal, intrathecal, and subarachnoid. Intrathecal half-life is 3.4 hours and Intravascular half-life is approximately 2 hours with normal renal function. Iohexol is available in a dosage strength of 10 mL, 20 mL, 50 mL, 100 mL supplied in a glass vial or glass bottle. The Intrathecal administration of Iohexol in adults is 180 mg or 240 mg or 300 mg of iodine per mL for lumbar, thoracic, cervical, and total columnar myelography. In pediatrics, Iohexol 180 mg of iodine per mL is administered intravascularly for lumbar, thoracic, cervical, and total columnar myelography. The intravascular administration of iohexol in adults is 140 mg of iodine per mL is given for intra-arterial digital subtraction angiography of the head, neck, abdominal, renal, and peripheral vessels. Iohexol 240 is administered intravascularly for CT head imaging and for peripheral venography. In pediatrics, iohexol 240 is administered for CT head and body imaging, and Iohexol 300 is used for angiocardiography, excretory urography, and CT head and body imaging. For oral and rectal administration, iohexol 350 is given for oral radiographic examination of the gastrointestinal tract while iohexol 180, 240, 300 is administered orally and rectally for radiographic examination of the gastrointestinal tract. Iohexol is recommended to store at a controlled room temperature of 20° C - 25° C (68° F - 77° F). Excursions permitted to 15° C to 30° C (59° F to 86° F).

Wholesale Price of Iohexol

The wholesale price of Iohexol 350 injectable solution (350 mg/mL) is around $ 130.08 for a supply of 125 milliliters with per unit cost at $ 1.04, and the cost for 500 milliliters is priced between $ 536.50 - $ 588.98 with unit price available for $ 1.07 - $ 1.18 depending up on the pharmacy one visit.

Iohexol - Mechanism of Action

The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohexol provides time-dependent image contrast which may assist in visualizing body structures. Iohexol is absorbed from cerebrospinal fluid (CSF) into the bloodstream and is eliminated by renal excretion. No significant metabolism, deiodination, or biotransformation occurs. After intrathecal administration into the subarachnoid space, diffusion of iohexol in the CSF allows the visualization of the subarachnoid spaces of the head and spinal canal. After intravascular administration, iohexol makes opaque vessels in its path of flow, allowing visualization of the internal structures until significant hemodilution occurs.

Finding Iohexol Manufacturers and Suppliers

To find a trustworthy partner in our business is one of the biggest challenges and to defeat that and to make one’s work/life easy in finding the reliable manufacturer and supplier of Iohexol one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of Iohexol. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects the proprietor with the consumers for business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible